170 related articles for article (PubMed ID: 9291814)
21. Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology.
Page BR; Pappas L; Cooke EW; Gaffney DK
Int J Gynecol Cancer; 2012 May; 22(4):593-8. PubMed ID: 22343970
[TBL] [Abstract][Full Text] [Related]
22. Cervical sarcomas: an analysis of incidence and outcome.
Wright JD; Rosenblum K; Huettner PC; Mutch DG; Rader JS; Powell MA; Gibb RK
Gynecol Oncol; 2005 Nov; 99(2):348-51. PubMed ID: 16051326
[TBL] [Abstract][Full Text] [Related]
23. High incidence of gynecologic sarcomas in Israel-A comparison to European and American reports: Gynecologic Sarcoma in Israel.
Brudner Y; Salman L; Haran G; Blecher A; Hallak M; Bruchim I
Maturitas; 2021 Dec; 154():1-6. PubMed ID: 34736574
[TBL] [Abstract][Full Text] [Related]
24. Incidence of uterine sarcomas in West Bohemia, at the Department of Gynaecology and Obstetrics, University Hospital in Pilsen, Czech Republic.
Kosťun J; Bouda J; Vlasák P; Bartáková A; Berezovskiy D; Weinberger V; Presl J
Ceska Gynekol; 2017; 82(6):436-442. PubMed ID: 29302976
[TBL] [Abstract][Full Text] [Related]
25. Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcoma.
Oláh KS; Dunn JA; Gee H
Br J Obstet Gynaecol; 1992 Jul; 99(7):590-4. PubMed ID: 1326319
[TBL] [Abstract][Full Text] [Related]
26. Uterine morcellation and survival in uterine sarcomas.
Bretthauer M; Goderstad JM; Løberg M; Emilsson L; Ye W; Adami HO; Kalager M
Eur J Cancer; 2018 Sep; 101():62-68. PubMed ID: 30025231
[TBL] [Abstract][Full Text] [Related]
27. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
[TBL] [Abstract][Full Text] [Related]
28. Sarcoma of the uterus. A clinical study of 42 patients.
Jereczek B; Jassem J; Kobierska A
Arch Gynecol Obstet; 1996; 258(4):171-80. PubMed ID: 8844134
[TBL] [Abstract][Full Text] [Related]
29. The risk of developing uterine sarcoma after tamoxifen use.
Lavie O; Barnett-Griness O; Narod SA; Rennert G
Int J Gynecol Cancer; 2008; 18(2):352-6. PubMed ID: 18334013
[TBL] [Abstract][Full Text] [Related]
30. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas.
Sorbe B; Johansson B
Int J Oncol; 2008 May; 32(5):1111-7. PubMed ID: 18425339
[TBL] [Abstract][Full Text] [Related]
32. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
[TBL] [Abstract][Full Text] [Related]
34. Uterine sarcoma in Israel: a study of 104 cases.
Schwartz Z; Dgani R; Lancet M; Kessler I
Gynecol Oncol; 1985 Mar; 20(3):354-63. PubMed ID: 2982707
[TBL] [Abstract][Full Text] [Related]
35. Uterine sarcomas at Ramathibodi Hospital (1969-1986).
Tangtrakul S; Srisupundit S; Linasmita V; Bullangpoti S; Bhamarapravati Y
J Med Assoc Thai; 1990 Feb; 73 Suppl 1():11-4. PubMed ID: 2351906
[TBL] [Abstract][Full Text] [Related]
36. Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: 10 Years' Experience.
Paul PG; Rengaraj V; Das T; Garg R; Thomas M; Khurd AS
J Minim Invasive Gynecol; 2016; 23(3):384-9. PubMed ID: 26677821
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of endometrial stromal sarcoma from an academic medical hospital in China.
Jin Y; Pan L; Wang X; Dai Z; Huang H; Guo L; Shen K; Lian L
Int J Gynecol Cancer; 2010 Dec; 20(9):1535-9. PubMed ID: 21370596
[TBL] [Abstract][Full Text] [Related]
38. Uterine sarcomas.
Mbatani N; Olawaiye AB; Prat J
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
[TBL] [Abstract][Full Text] [Related]
39. Nationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort: 30-year population-based registry in Taiwan.
Huang CY; Chen CA; Chen YL; Chiang CJ; Hsu TH; Lin MC; Lai MS; Chen CJ; You SL; Cheng WF
PLoS One; 2012; 7(12):e51372. PubMed ID: 23251510
[TBL] [Abstract][Full Text] [Related]
40. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.
Sumi A; Terasaki H; Sanada S; Uchida M; Tomioka Y; Kamura T; Yano H; Abe T
Magn Reson Med Sci; 2015; 14(4):295-304. PubMed ID: 26104072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
